Literature DB >> 25367656

The cancer genome atlas research network: a sight to behold.

Thomas J Giordano1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25367656     DOI: 10.1007/s12022-014-9345-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


× No keyword cloud information.
  13 in total

1.  Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.

Authors:  Tarik M Elsheikh; Sylvia L Asa; John K C Chan; Ronald A DeLellis; Clara S Heffess; Virginia A LiVolsi; Bruce M Wenig
Journal:  Am J Clin Pathol       Date:  2008-11       Impact factor: 2.493

2.  Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.

Authors:  Thomas J Giordano; Rork Kuick; Dafydd G Thomas; David E Misek; Michelle Vinco; Donita Sanders; Zhaowen Zhu; Raffaele Ciampi; Michael Roh; Kerby Shedden; Paul Gauger; Gerard Doherty; Norman W Thompson; Samir Hanash; Ronald J Koenig; Yuri E Nikiforov
Journal:  Oncogene       Date:  2005-10-06       Impact factor: 9.867

3.  Interobserver variability amongst cytopathologists and histopathologists in the diagnosis of neoplastic follicular patterned lesions of thyroid.

Authors:  Rajan Duggal; Arvind Rajwanshi; Nalini Gupta; Rakesh Kumar Vasishta
Journal:  Diagn Cytopathol       Date:  2011-04       Impact factor: 1.582

4.  Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.

Authors:  Thomas J Giordano; Amy Y M Au; Rork Kuick; Dafydd G Thomas; Daniel R Rhodes; Kenneth G Wilhelm; Michelle Vinco; David E Misek; Donita Sanders; Zhaowen Zhu; Raffaele Ciampi; Samir Hanash; Arul Chinnaiyan; Roderick J Clifton-Bligh; Bruce G Robinson; Yuri E Nikiforov; Ronald J Koenig
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

5.  Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.

Authors:  Ricardo V Lloyd; Lori A Erickson; Mary B Casey; King Y Lam; Christine M Lohse; Sylvia L Asa; John K C Chan; Ronald A DeLellis; H Ruben Harach; Kennichi Kakudo; Virginia A LiVolsi; Juan Rosai; Thomas J Sebo; Manuel Sobrinho-Simoes; Bruce M Wenig; Marick E Lae
Journal:  Am J Surg Pathol       Date:  2004-10       Impact factor: 6.394

Review 6.  Genome-wide studies in thyroid neoplasia.

Authors:  Thomas J Giordano
Journal:  Endocrinol Metab Clin North Am       Date:  2008-06       Impact factor: 4.741

7.  Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

Authors:  Yuri E Nikiforov; Sally E Carty; Simon I Chiosea; Christopher Coyne; Umamaheswar Duvvuri; Robert L Ferris; William E Gooding; Steven P Hodak; Shane O LeBeau; N Paul Ohori; Raja R Seethala; Mitchell E Tublin; Linwah Yip; Marina N Nikiforova
Journal:  Cancer       Date:  2014-09-10       Impact factor: 6.860

8.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

9.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

View more
  12 in total

Review 1.  Computational approaches to study the effects of small genomic variations.

Authors:  Kamil Khafizov; Maxim V Ivanov; Olga V Glazova; Sergei P Kovalenko
Journal:  J Mol Model       Date:  2015-09-08       Impact factor: 1.810

2.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

Review 3.  Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro; Luis Otávio Sarian; Manoela Marques Ortega; Sophie Françoise Derchain
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

4.  Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma.

Authors:  Wei-Chou Lin; Fu-Shun Hsu; Kuan-Lin Kuo; Shing-Hwa Liu; Chia-Tung Shun; Chung-Sheng Shi; Hong-Chiang Chang; Yu-Chieh Tsai; Ming-Chieh Lin; June-Tai Wu; Yu Kuo; Po-Ming Chow; Shih-Ming Liao; Shao-Ping Yang; Jo-Yu Hong; Kuo-How Huang
Journal:  J Mol Med (Berl)       Date:  2018-10-04       Impact factor: 4.599

5.  MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.

Authors:  Y Liu; Z Niu; X Lin; Y Tian
Journal:  Cancer Gene Ther       Date:  2017-03-10       Impact factor: 5.987

Review 6.  Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

Authors:  Rick Kamps; Rita D Brandão; Bianca J van den Bosch; Aimee D C Paulussen; Sofia Xanthoulea; Marinus J Blok; Andrea Romano
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

7.  Transcriptome Based System Biology Exploration Reveals Homogeneous Tumorigenicity of Alimentary Tract Malignancy.

Authors:  Yu-Chen Lu; Jing-Qi Shi; Zi-Xin Zhang; Jia-Yi Zhou; Hai-Kun Zhou; Yuan-Cai Feng; Zhen-Hua Lu; Shu-Ya Yang; Xi-Yang Zhang; Yang Liu; Zi-Chao Li; Yuan-Jie Sun; Lian-He Zheng; Dong-Bo Jiang; Kun Yang
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

8.  Identification of the Molecular Subgroups in Idiopathic Pulmonary Fibrosis by Gene Expression Profiles.

Authors:  Ning Zhang; Yali Guo; Cong Wu; Bohan Jiang; Yuguang Wang
Journal:  Comput Math Methods Med       Date:  2021-10-04       Impact factor: 2.238

9.  Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.

Authors:  Shuo Fang; Yongdong Dai; Yan Mei; Mingming Yang; Liang Hu; Hong Yang; Xininyuan Guan; Jiangchao Li
Journal:  Thorac Cancer       Date:  2019-01-03       Impact factor: 3.500

10.  The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study.

Authors:  Kuan-Lin Kuo; Shing-Hwa Liu; Wei-Chou Lin; Po-Ming Chow; Yu-Wei Chang; Shao-Ping Yang; Chung-Sheng Shi; Chen-Hsun Hsu; Shih-Ming Liao; Hong-Chiang Chang; Kuo-How Huang
Journal:  Cells       Date:  2019-10-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.